Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph Rischpler

Showing results (101-110 of 184) with videos related to

Pageof 19
Sort By:
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2012
PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathyPaco E Bravo, Aurélio Pinheiro, Takahiro Higuchi, et al.
Scientific Reports|September 2, 2021
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.
EJNMMI Physics|February 15, 2021
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerDavid Kersting, Walter Jentzen, Miriam Sraieb, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 1, 2023
Quantification performance of silicon photomultiplier-based PET for small <sup>18</sup>F-, <sup>68</sup>Ga- and <sup>124</sup>I-avid lesions in the context of radionuclide therapy planningDavid Kersting, Alexandros Moraitis, Miriam Sraieb, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2020
EANM procedural guidelines for PET/CT quantitative myocardial perfusion imagingRoberto Sciagrà, Mark Lubberink, Fabien Hyafil, et al.
Experimental Hematology|March 19, 2008
G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cellsStefan Brunner, Bruno C Huber, Rebekka Fischer, et al.
Cancers|April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCDavid Kersting, Robert Seifert, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaInes Maric, Manuel Weber, Andre Prochnow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2022
Lesion Quantification Accuracy of Digital <sup>90</sup>Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide TherapyDavid Kersting, Walter Jentzen, Daniel Jeromin, et al.
ESC Heart Failure|February 18, 2022
Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosisMaria Papathanasiou, Aiste-Monika Jakstaite, Sara Oubari, et al.
Pageof 19

Showing results (101-110 of 184) with videos related to

Sort By:
Pageof 19
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 9, 2012
PET/CT assessment of symptomatic individuals with obstructive and nonobstructive hypertrophic cardiomyopathyPaco E Bravo, Aurélio Pinheiro, Takahiro Higuchi, et al.
Scientific Reports|September 2, 2021
Silicon-photomultiplier-based PET/CT reduces the minimum detectable activity of iodine-124David Kersting, Walter Jentzen, Pedro Fragoso Costa, et al.
EJNMMI Physics|February 15, 2021
Comparing lesion detection efficacy and image quality across different PET system generations to optimize the iodine-124 PET protocol for recurrent thyroid cancerDavid Kersting, Walter Jentzen, Miriam Sraieb, et al.
Physica Medica : PM : an International Journal Devoted to the Applications of Physics to Medicine and Biology : Official Journal of the Italian Association of Biomedical Physics (AIFB)|October 1, 2023
Quantification performance of silicon photomultiplier-based PET for small <sup>18</sup>F-, <sup>68</sup>Ga- and <sup>124</sup>I-avid lesions in the context of radionuclide therapy planningDavid Kersting, Alexandros Moraitis, Miriam Sraieb, et al.
European Journal of Nuclear Medicine and Molecular Imaging|November 2, 2020
EANM procedural guidelines for PET/CT quantitative myocardial perfusion imagingRoberto Sciagrà, Mark Lubberink, Fabien Hyafil, et al.
Experimental Hematology|March 19, 2008
G-CSF treatment after myocardial infarction: impact on bone marrow-derived vs cardiac progenitor cellsStefan Brunner, Bruno C Huber, Rebekka Fischer, et al.
Cancers|April 30, 2021
Predictive Factors for RAI-Refractory Disease and Short Overall Survival in PDTCDavid Kersting, Robert Seifert, Lukas Kessler, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|February 2, 2023
Efficacy and Safety of <sup>124</sup>I-MIBG Dosimetry-Guided High-Activity <sup>131</sup>I-MIBG Therapy of Advanced Pheochromocytoma or NeuroblastomaInes Maric, Manuel Weber, Andre Prochnow, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 18, 2022
Lesion Quantification Accuracy of Digital <sup>90</sup>Y PET Imaging in the Context of Dosimetry in Systemic Fibroblast Activation Protein Inhibitor Radionuclide TherapyDavid Kersting, Walter Jentzen, Daniel Jeromin, et al.
ESC Heart Failure|February 18, 2022
Clinical features and predictors of atrial fibrillation in patients with light-chain or transthyretin cardiac amyloidosisMaria Papathanasiou, Aiste-Monika Jakstaite, Sara Oubari, et al.
Pageof 19